Product Information
MARAVIROC 300 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $7.0607 per EA under NDC 70710193106. Its NADAC has been published 41 times since Sep 24, 2025.
Strength
300 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710193106
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MARAVIROCApproval Type
Generic (ANDA)
FDA Application
ANDA217880On Market Since
5/23/2025
Pharmacological Classes
Price Statistics
The NADAC for MARAVIROC 300 MG TABLET has been published 41 times since Sep 24, 2025, and over the history we have for it it has declined 36.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.0607 per EA |
|---|---|
| All-time high | $11.1701 (Oct 15, 2025) |
| All-time low | $7.0607 (Jun 17, 2026) |
| 52-week high | $11.1701 |
| 52-week low | $7.0607 |
| Median price | $10.1209 |
| Average price | $9.6338 |
| Largest weekly change | -11.8% (Jun 17, 2026) |
| Weeks tracked | 41 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MARAVIROC 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MARAVIROC 300 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $7.0607 per EA (NDC 70710193106), effective Jul 1, 2026.
How has the price of MARAVIROC 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for MARAVIROC 300 MG TABLET has declined 36.8%. It has been tracked across 41 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for MARAVIROC 300 MG TABLET?
Since Sep 24, 2025, the NADAC for MARAVIROC 300 MG TABLET has ranged from a low of $7.0607 (Jun 17, 2026) to a high of $11.1701 (Oct 15, 2025), with a median of $10.1209 per EA.
Are there cheaper alternatives to MARAVIROC 300 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as MARAVIROC 300 MG TABLET, but none are currently priced below it.
Who manufactures MARAVIROC 300 MG TABLET?
MARAVIROC 300 MG TABLET (NDC 70710193106) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification